Rejoin Medical Secures ￥100 Million in Series B Funding - vcbeat
Summary
(VCBeat) Aug. 2, 2021 -- Recently, Rejoin Medical, a leader in sports medicine, announced the completion of a Series B financing of hundreds of millions. It is reported that the funds raised will be used to develop new products and basic materials, build domestic and foreign sales teams, and carry out professional marketing activities.Rejoin Medical is an orthopedic device company of minimally invasive surgery with sports medicine as its core. With more than 50 independent patents, Rejoin Medical is committed to providing more simple and reliable overall solutions for doctors and patients in the field of sports medicine and surgeon-designed minimally invasive technologies. He founded Rejoin Medical in 2010 and has accumulated rich experience in the production of orthopedics products and a deep insight into the global sports medicine field during the cooperation with internationally renowned orthopedic device manufacturers such as Zimmer Biomet.In 2021, Rejoin Medical will obtain Class III or Class II registration certificates for a number of series products such as all-suture anchors. Vertex Ventures China invests in high-growth innovative start-ups across mainland China, covering the fields of deep tech, new digital economy, and healthcare.Addor Capital offers investment services by financing early-stage ventures and holding securities of other companies.